[1]
Nellaiappan, K.; Yerra, V.G.; Kumar, A. Role of AMPK in diabetic cardiovascular complications: An overview. Cardiovasc. Hematol. Disord. Drug Targets, 2019, 19(1), 5-13.
[2]
Sarkar, A.; Rafiq, K. Humoral immunity in heart failure. Cardiovasc. Hematol. Disord. Drug Targets, 2019, 19(1), 14-18.
[3]
Mittal, R.; Jhaveri, V.M.; Samantha Kay, S.I.; Blackwelder, P.; Patel, K. Pseudomonas aeruginosa invades human aortic endothelial cells and induces cell damage in vitro. Cardiovasc. Hematol. Disorders-Drug Targ., 2019, 19(1), 45-50.
[4]
Mittal, R.; Jhaveri, V.M.; Samantha Kay, S.I.; Greer, A.; Sutherland, K.J.; McMurry, H.S.; Lin, N.; Mittal, J.; Malhotra, A.K.; Patel, A.P. Recent advances in understanding the pathogenesis of cardiovascular diseases and development of treatment modalities. Cardiovasc. Hematol. Disord. Drug Targets, 2019, 19(1), 19-32.
[5]
Gupta, P.; Garcia, E.; Sarkar, A.; Kapoor, S.; Rafiq, K.; Chand, H.S.; Nair, M.; Jayant, R.D. Nanoparticle based treatment for cardiovascular diseases. Cardiovasc. Hematol. Disord. Drug Targets, 2019, 19(1), 33-44.
